A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Geron Corp stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 372,759 shares of GERN stock, worth $1.49 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
372,759
Previous 296,743 25.62%
Holding current value
$1.49 Million
Previous $1.26 Million 34.5%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.17 - $4.99 $316,986 - $379,319
76,016 Added 25.62%
372,759 $1.69 Million
Q2 2024

Aug 14, 2024

BUY
$3.1 - $5.09 $919,903 - $1.51 Million
296,743 New
296,743 $1.26 Million

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.51B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.